Targeted Alpha Therapy (TAT)-Advancement of Medical Technology in India
Targeted Alpha Therapy (TAT) is a novel radiopharmaceutical therapy where alpha emitting radio-isotopes like Bismuth 213 are conjugated with specific tumor directed ligands and used to treat various kinds of cancer. Currently the two cancers being targeted are metastatic prostate cancer and neuroendocrine tumors. FMRI would be the first organisation in Asia to start this therapy. Currently this therapy is available in a few selected centers in Germany and the US only. The targeted alpha therapies offer a ray of hope to patients who have failed many other lines of treatments. The clinical success of TAT has already been proven in various studies worldwide. Patients can be treated as day care requiring admission for 6 hours. Each patient will require two admissions in day care on alternate days. Our first TAT generator is scheduled to arrive on 3rd of July 2017.